U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Unknown
149124
Name Type Language
BRENTUXIMAB
Common Name English
CAC-10
Preferred Name English
MOAB, CHIMERIC, SGN-30, TO CD30 ANTIGEN
Common Name English
CAC10
Code English
BRENTUXIMAB VEDOTIN BRENTUXIMAB [MI]
Common Name English
IMMUNOGLOBULIN G1, ANTI-(HUMAN CD30 (ANTIGEN)) (HUMAN-MOUSE MONOCLONAL SGN-30 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL SGN-30 .KAPPA.-CHAIN, DIMER
Systematic Name English
MONOCLONAL ANTIBODY SGN-30
Common Name English
Classification Tree Code System Code
NCI_THESAURUS C129822
Created by admin on Mon Mar 31 21:45:05 GMT 2025 , Edited by admin on Mon Mar 31 21:45:05 GMT 2025
FDA ORPHAN DRUG 171303
Created by admin on Mon Mar 31 21:45:05 GMT 2025 , Edited by admin on Mon Mar 31 21:45:05 GMT 2025
NCI_THESAURUS C20401
Created by admin on Mon Mar 31 21:45:05 GMT 2025 , Edited by admin on Mon Mar 31 21:45:05 GMT 2025
FDA ORPHAN DRUG 178203
Created by admin on Mon Mar 31 21:45:05 GMT 2025 , Edited by admin on Mon Mar 31 21:45:05 GMT 2025
Code System Code Type Description
CAS
775303-41-8
Created by admin on Mon Mar 31 21:45:05 GMT 2025 , Edited by admin on Mon Mar 31 21:45:05 GMT 2025
PRIMARY
NCI_THESAURUS
C2007
Created by admin on Mon Mar 31 21:45:05 GMT 2025 , Edited by admin on Mon Mar 31 21:45:05 GMT 2025
PRIMARY
EVMPD
SUB118571
Created by admin on Mon Mar 31 21:45:05 GMT 2025 , Edited by admin on Mon Mar 31 21:45:05 GMT 2025
ALTERNATIVE
SMS_ID
100000175007
Created by admin on Mon Mar 31 21:45:05 GMT 2025 , Edited by admin on Mon Mar 31 21:45:05 GMT 2025
PRIMARY
FDA UNII
C67ORA155P
Created by admin on Mon Mar 31 21:45:05 GMT 2025 , Edited by admin on Mon Mar 31 21:45:05 GMT 2025
PRIMARY
DRUG BANK
DB05471
Created by admin on Mon Mar 31 21:45:05 GMT 2025 , Edited by admin on Mon Mar 31 21:45:05 GMT 2025
PRIMARY
MERCK INDEX
m2645
Created by admin on Mon Mar 31 21:45:05 GMT 2025 , Edited by admin on Mon Mar 31 21:45:05 GMT 2025
PRIMARY
ChEMBL
CHEMBL2109256
Created by admin on Mon Mar 31 21:45:05 GMT 2025 , Edited by admin on Mon Mar 31 21:45:05 GMT 2025
PRIMARY
ACTIVE MOIETY
BRENTUXIMAB
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966